Nautilus Biotechnology Inc NAUT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/24/22 EDT
3.02UNCH (UNCH)
Volume
1,010,466
Close
3.02quote price arrow down-0.11 (-3.51%)
Volume
4,441,101
52 week range
2.55 - 12.38
Loading...
  • Open3.08
  • Day High3.21
  • Day Low2.99
  • Prev Close3.13
  • 52 Week High12.38
  • 52 Week High Date08/05/21
  • 52 Week Low2.55
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap375.87M
  • Shares Out124.46M
  • 10 Day Average Volume0.47M
  • Dividend-
  • Dividend Yield-
  • Beta0.21
  • YTD % Change-41.7

KEY STATS

  • Open3.08
  • Day High3.21
  • Day Low2.99
  • Prev Close3.13
  • 52 Week High12.38
  • 52 Week High Date08/05/21
  • 52 Week Low2.55
  • 52 Week Low Date06/16/22
  • Market Cap375.87M
  • Shares Out124.46M
  • 10 Day Average Volume0.47M
  • Dividend-
  • Dividend Yield-
  • Beta0.21
  • YTD % Change-41.7

RATIOS/PROFITABILITY

  • EPS (TTM)-0.46
  • P/E (TTM)-6.51
  • Fwd P/E (NTM)-3.91
  • EBITDA (TTM)-57.017M
  • ROE (TTM)-36.86%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-642.20%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/10/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nautilus Biotechnology Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Nautilus Biotechnology, Inc. is a development stage life sciences company. The Company is engaged in creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company focused on transforming the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its platform end-to-end solution comprised of the proteome analysis system, consumables, and software. The...
Address
2701 Eastlake Ave East, Suite 202
Seattle, WA
98102
United States

Top Peers

SYMBOLLASTCHG%CHG
INO
Inovio Pharmaceuticals Inc
1.94-0.07-3.48%
VERA
Vera Therapeutics Inc
14.20+0.58+4.26%
GBIO
Generation Bio Co
7.00-0.02-0.28%
HUMA
Humacyte Inc
3.32-0.27-7.52%
VXRT
Vaxart Inc
3.78+0.09+2.44%